Ticagrelor attenuates the increase of extracellular vesicle concentrations in plasma after acute myocardial infarction compared to clopidogrel

BACKGROUND: Platelet P2Y12 antagonist ticagrelor reduces mortality after acute myocardial infarction (AMI) compared to clopidogrel, but the underlying mechanism is unknown. Because activated platelets, leukocytes, and endothelial cells release proinflammatory and prothrombotic extracellular vesicles...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Thromb Haemost
Main Authors: Gasecka, Aleksandra, Nieuwland, Rienk, Budnik, Monika, Dignat‐George, Françoise, Eyileten, Ceren, Harrison, Paul, Lacroix, Romaric, Leroyer, Aurélie, Opolski, Grzegorz, Pluta, Kinga, van der Pol, Edwin, Postuła, Marek, Siljander, Pia, Siller‐Matula, Jolanta M., Filipiak, Krzysztof J.
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2020
Assuntos:
THROMBOSIS
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7065161/
https://ncbi.nlm.nih.gov/pubmed/31833175
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jth.14689
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados